| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 56.0016 | 61 |
| GSM780708 | Untreated after 4 days (C2_1) | 55.548 | 60 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.439 | 50 |
| GSM780719 | Untreated after 4 days (C1_2) | 67.3521 | 68 |
| GSM780720 | Untreated after 4 days (C2_2) | 66.3991 | 68 |
| GSM780721 | Untreated after 4 days (C3_2) | 55.4347 | 60 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 59.8641 | 64 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 63.0528 | 66 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 61.6906 | 65 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.0107 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 71.3396 | 69 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 79.9346 | 72 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.8178 | 59 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 60.5493 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 63.7344 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 63.8052 | 67 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 61.0352 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 62.1 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 71.194 | 69 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 65.435 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 59.2887 | 64 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 72.8158 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 64.2306 | 67 |